Female Cancer Patients' Preference For Sexual Health Interventions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01084642|
Recruitment Status : Completed
First Posted : March 10, 2010
Last Update Posted : July 6, 2017
The purpose of this study is to survey female cancer patients' awareness of and preference for methods to improve sexual health. This information will help to improve our understanding of the needs and preferences for sexual health strategies and interventions of our female patients.
The findings of this survey will also be used to develop feasible sexual health resources for our patients and enhance the success of grant proposals to support future sexual health interventions at MSKCC.
|Condition or disease|
|Breast Cancer Gynecologic Cancer|
|Study Type :||Observational|
|Actual Enrollment :||229 participants|
|Official Title:||A Pilot Study Surveying Female Cancer Patients' Preference For Sexual Health Interventions|
|Actual Study Start Date :||March 4, 2010|
|Actual Primary Completion Date :||July 3, 2017|
|Actual Study Completion Date :||July 3, 2017|
Participants will be asked to complete a survey as a one time assessment.
- Participant' awareness of sexual health issues & preference for sexual health intervention [ Time Frame: 2 years ]
- To assess & describe female cancer patients' attitudes towards & preference of methods to receive sexual health information (verbal or written) & psychosexual education patient information cards or intervention modality (telephone, in-person or online). [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01084642
|United States, New York|
|Memorial Sloan Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Jeanne Carter, PhD||Memorial Sloan Kettering Cancer Center|